Loading clinical trials...
Loading clinical trials...
Oxytocin to Enhance Integrated Exposure-Based Treatment of Co-occurring Alcohol Use Disorder and PTSD
Conditions
Interventions
40 IU Intranasal Oxytocin
Placebo
+1 more
Locations
1
United States
Medical University of South Carolina
Charleston, South Carolina, United States
Start Date
March 29, 2021
Primary Completion Date
June 1, 2026
Completion Date
December 1, 2026
Last Updated
April 9, 2026
NCT07027839
NCT06956781
NCT06552741
NCT07279558
NCT07341230
NCT07473505
Lead Sponsor
Medical University of South Carolina
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions